| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 336.30B | 240.19B | 179.20B | 147.96B | 101.61B |
| Gross Profit | 46.38B | 38.20B | 27.42B | 20.90B | 17.41B |
| EBITDA | 26.19B | 11.02B | 5.23B | 3.90B | 4.30B |
| Net Income | 16.42B | 16.63B | 5.31B | 5.26B | 4.85B |
Balance Sheet | |||||
| Total Assets | 290.53B | 229.39B | 192.60B | 157.83B | 134.34B |
| Cash, Cash Equivalents and Short-Term Investments | 68.25B | 40.87B | 35.75B | 33.34B | 28.01B |
| Total Debt | 23.12B | 6.51B | 8.10B | 13.16B | 4.51B |
| Total Liabilities | 196.88B | 136.97B | 107.45B | 81.63B | 64.12B |
| Stockholders Equity | 92.44B | 86.74B | 80.51B | 75.13B | 68.61B |
Cash Flow | |||||
| Free Cash Flow | 42.71B | 23.47B | 7.02B | 5.68B | 9.25B |
| Operating Cash Flow | 46.73B | 26.51B | 22.34B | 16.02B | 15.35B |
| Investing Cash Flow | -24.45B | -9.13B | -16.14B | -12.13B | -7.16B |
| Financing Cash Flow | -1.42B | -13.30B | -2.76B | 1.33B | 916.02M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$258.31B | 9.90 | 18.03% | 1.95% | ― | ― | |
66 Neutral | HK$177.87B | 12.11 | 11.66% | 3.41% | 7.93% | -12.94% | |
64 Neutral | HK$977.57B | 24.33 | 14.29% | 1.55% | 22.94% | 10.22% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$146.56B | 107.16 | 1.55% | ― | -10.21% | -54.95% | |
53 Neutral | HK$129.45B | -122.26 | -9.33% | ― | 86.21% | 51.50% |